| human | Q5 |
| P6178 | Dimensions author ID | 012673177637.19 |
| P11303 | IRIS UNIBA author ID | 09067 |
| P496 | ORCID iD | 0000-0003-3490-7703 |
| P1153 | Scopus author ID | 57191280801 |
| P69 | educated at | University of Bari | Q1236136 |
| P108 | employer | Center for Research in Biological Chemistry and Molecular Materials | Q72941743 |
| P735 | given name | Maria | Q325872 |
| Maria | Q325872 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q104610620 | 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition |
| Q47935638 | Effect of Nitrogen Atom Substitution in A3 Adenosine Receptor Binding: N-(4,6-Diarylpyridin-2-yl)acetamides as Potent and Selective Antagonists |
| Q38698576 | Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides. |
| Q98202387 | Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine |
| Q47417018 | Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors |
| Q90304709 | Trifluorinated Pyrimidine-Based A2B Antagonists: Optimization and Evidence of Stereospecific Recognition |
Search more.